National Center for Advancing Translational Sciences in Oregon
National Center for Advancing Translational Sciences (93.350) awarded $55.9 million to recipients in Oregon in 13 grants from fiscal 2021 to 2025, 1.8% of the program's national total. Oregon Health & Science University received the most, $54.7 million.
- Awarded in Oregon$55.9 million
- Awards13
- Share of the program1.8%
- Rank among states21st of 41
- National total$3.1 billion
By year
| Fiscal year | Awards | Amount |
|---|---|---|
| FY 2021 | 7 | $9.6 million |
| FY 2022 | 6 | $12.4 million |
| FY 2023 | 9 | $13.7 million |
| FY 2024 | 4 | $9.3 million |
| FY 2025 | 4 | $10.9 million |
Recipients in Oregon
| Recipient | Type | Awards | Amount |
|---|---|---|---|
| Oregon Health & Science University | Colleges and universities | 5 | $54.7 million |
| Elex Biotech, Inc | Small businesses | 1 | $500,000 |
| Penderia Technologies Inc | Small businesses | 1 | $256,223 |
| University of Oregon | Colleges and universities | 1 | $147,500 |
| Oregon State University | Colleges and universities | 1 | $141,075 |
| Children's Cancer Therapy Development Institute | Nonprofits | 1 | $140,000 |
| Pediatric Dermatology Research Alliance Inc | Nonprofits | 3 | $28,457 |
Open opportunities under this program
- Competing Revisions to Existing NIH Single Project Research Grants and Cooperative Agreements (Clinical Trial Optional)
- NIH, CDC and FDA Small Business Innovation Research Grant (Parent SBIR [R43/R44] Clinical Trial Optional)
- NIH Small Business Technology Transfer Grant (Parent STTR [R41/R42] Clinical Trial Optional)
- Limited Competition: NCATS Clinical and Translational Science Award (CTSA) Program Research Education Grants Programs (R25 - Clinical Trial Not Allowed)
- Preclinical Proof of Concept Studies for Rare Diseases (R21 Clinical Trial Not Allowed)
- Change of Recipient Organization (Type 7 Parent Clinical Trial Optional)
- Successor-in-Interest (Type 6 Parent Clinical Trial Optional)
- NIH Support for Conferences and Scientific Meetings (Parent R13 Clinical Trial Not Allowed)
- Clinical and Translational Science Award (UM1 Clinical Trial Optional)
- Limited Competition: Mentored Research Career Development Program Award in Clinical and Translational Science Awards (CTSA) Program (K12 Clinical Trial Optional)
See all 34 on the program page
Questions people ask
How much National Center for Advancing Translational Sciences money goes to Oregon?
$55.9 million from fiscal 2021 to 2025, across 13 awards. Oregon ranks 21st of 41 states and territories for this program.
Who receives National Center for Advancing Translational Sciences money in Oregon?
The largest recipient is Oregon Health & Science University, with $54.7 million in 5 awards. Next are Elex Biotech, Inc and Penderia Technologies Inc.
Can organizations in Oregon apply now?
Yes, 34 opportunities under this program are open or forecast on Grants.gov. Federal grants are national, so eligibility depends on the notice, not the state.
National Center for Advancing Translational Sciences in other states
Other large programs in Oregon
- Grants to States for Medicaid
- Highway Planning and Construction
- Children's Health Insurance Program
- Disaster Grants - Public Assistance (Presidentially Declared Disasters)
- Education Stabilization Fund
- National School Lunch Program
- Federal Transit Formula Grants
- Head Start
- Temporary Assistance for Needy Families
- Child Care and Development Block Grant